Literature DB >> 29800605

Neuronal excitatory amino acid transporter EAAT3: Emerging functions in health and disease.

Suzanne M Underhill1, Susan L Ingram2, Susanne E Ahmari3, Jeremy Veenstra-VanderWeele4, Susan G Amara5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29800605      PMCID： PMC7014962          DOI： 10.1016/j.neuint.2018.05.012

Source DB:  PubMed          Journal:  Neurochem Int        ISSN： 0197-0186            Impact factor:   3.921


× No keyword cloud information.
  96 in total

1.  Functional studies and rare variant screening of SLC1A1/EAAC1 in males with obsessive-compulsive disorder.

Authors:  Jeremy Veenstra-VanderWeele; Tim Xu; Alicia M Ruggiero; Lauren R Anderson; Shaine T Jones; Joseph A Himle; James L Kennedy; Margaret A Richter; Gregory L Hanna; Paul D Arnold
Journal:  Psychiatr Genet       Date:  2012-10       Impact factor: 2.458

2.  Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes.

Authors:  R A Vaughan; R A Huff; G R Uhl; M J Kuhar
Journal:  J Biol Chem       Date:  1997-06-13       Impact factor: 5.157

3.  Amphetamine and Methamphetamine Increase NMDAR-GluN2B Synaptic Currents in Midbrain Dopamine Neurons.

Authors:  Ming-Hua Li; Suzanne M Underhill; Cheryl Reed; Tamara J Phillips; Susan G Amara; Susan L Ingram
Journal:  Neuropsychopharmacology       Date:  2016-12-15       Impact factor: 7.853

4.  Glutamate transporter type 3 regulates mouse hippocampal GluR1 trafficking.

Authors:  Jiangbei Cao; Hongying Tan; Weidong Mi; Zhiyi Zuo
Journal:  Biochim Biophys Acta       Date:  2014-01-08

5.  Comprehensive family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder.

Authors:  Jack Samuels; Ying Wang; Mark A Riddle; Benjamin D Greenberg; Abby J Fyer; James T McCracken; Scott L Rauch; Dennis L Murphy; Marco A Grados; James A Knowles; John Piacentini; Bernadette Cullen; O Joseph Bienvenu; Steven A Rasmussen; Daniel Geller; David L Pauls; Kung-Yee Liang; Yin Y Shugart; Gerald Nestadt
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-03-28       Impact factor: 3.568

6.  Isoflurane unveils a critical role of glutamate transporter type 3 in regulating hippocampal GluR1 trafficking and context-related learning and memory in mice.

Authors:  J Cao; Z Wang; W Mi; Z Zuo
Journal:  Neuroscience       Date:  2014-05-04       Impact factor: 3.590

7.  Heroin relapse requires long-term potentiation-like plasticity mediated by NMDA2b-containing receptors.

Authors:  Haowei Shen; Khaled Moussawi; Wenhua Zhou; Shigenobu Toda; Peter W Kalivas
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

8.  Deletion at the SLC1A1 glutamate transporter gene co-segregates with schizophrenia and bipolar schizoaffective disorder in a 5-generation family.

Authors:  Marina Myles-Worsley; Josepha Tiobech; Sharon R Browning; Jeremy Korn; Sarah Goodman; Karen Gentile; Nadine Melhem; William Byerley; Stephen V Faraone; Frank A Middleton
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-01-22       Impact factor: 3.568

9.  A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder.

Authors:  Jens R Wendland; Pablo R Moya; Kiara R Timpano; Adriana P Anavitarte; Matthew R Kruse; Michael G Wheaton; Renee F Ren-Patterson; Dennis L Murphy
Journal:  Arch Gen Psychiatry       Date:  2009-04

10.  Neurochemical and behavioral characterization of neuronal glutamate transporter EAAT3 heterozygous mice.

Authors:  Luis F González; Francisca Henríquez-Belmar; Claudia Delgado-Acevedo; Marisol Cisternas-Olmedo; Gloria Arriagada; Ramón Sotomayor-Zárate; Dennis L Murphy; Pablo R Moya
Journal:  Biol Res       Date:  2017-09-19       Impact factor: 5.612
View more
  10 in total

1.  Behavioral and synaptic alterations relevant to obsessive-compulsive disorder in mice with increased EAAT3 expression.

Authors:  Claudia Delgado-Acevedo; Sebastián F Estay; Anna K Radke; Ayesha Sengupta; Angélica P Escobar; Francisca Henríquez-Belmar; Cristopher A Reyes; Valentina Haro-Acuña; Elías Utreras; Ramón Sotomayor-Zárate; Andrew Cho; Jens R Wendland; Ashok B Kulkarni; Andrew Holmes; Dennis L Murphy; Andrés E Chávez; Pablo R Moya
Journal:  Neuropsychopharmacology       Date:  2018-12-26       Impact factor: 7.853

Review 2.  Neurotransmitters-Key Factors in Neurological and Neurodegenerative Disorders of the Central Nervous System.

Authors:  Raluca Ioana Teleanu; Adelina-Gabriela Niculescu; Eugenia Roza; Oana Vladâcenco; Alexandru Mihai Grumezescu; Daniel Mihai Teleanu
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

3.  Amphetamine Stimulates Endocytosis of the Norepinephrine and Neuronal Glutamate Transporters in Cultured Locus Coeruleus Neurons.

Authors:  Suzanne M Underhill; Mark S Colt; Susan G Amara
Journal:  Neurochem Res       Date:  2020-01-07       Impact factor: 3.996

Review 4.  Regulation of Glutamate, GABA and Dopamine Transporter Uptake, Surface Mobility and Expression.

Authors:  Renae M Ryan; Susan L Ingram; Annalisa Scimemi
Journal:  Front Cell Neurosci       Date:  2021-04-13       Impact factor: 5.505

Review 5.  Cysteine Donor-Based Brain-Targeting Prodrug: Opportunities and Challenges.

Authors:  Gaoyang Ni; Zhenbiao Hu; Ziteng Wang; Min Zhang; Xingyu Liu; Guihong Yang; Zhaowei Yan; Yang Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-02-24       Impact factor: 6.543

6.  Enhancement of Phosphorylation and Transport Activity of the Neuronal Glutamate Transporter Excitatory Amino Acid Transporter 3 by C3bot and a 26mer C3bot Peptide.

Authors:  Johannes Piepgras; Astrid Rohrbeck; Ingo Just; Stefan Bittner; Gudrun Ahnert-Hilger; Markus Höltje
Journal:  Front Cell Neurosci       Date:  2022-06-15       Impact factor: 6.147

7.  Altered baseline and amphetamine-mediated behavioral profiles in dopamine transporter Cre (DAT-Ires-Cre) mice compared to tyrosine hydroxylase Cre (TH-Cre) mice.

Authors:  Muhammad O Chohan; Sari Esses; Julia Haft; Susanne E Ahmari; Jeremy Veenstra-VanderWeele
Journal:  Psychopharmacology (Berl)       Date:  2020-08-10       Impact factor: 4.415

8.  Dysfunction of EAAT3 Aggravates LPS-Induced Post-Operative Cognitive Dysfunction.

Authors:  Xiao-Yan Wang; Wen-Gang Liu; Ai-Sheng Hou; Yu-Xiang Song; Yu-Long Ma; Xiao-Dong Wu; Jiang-Bei Cao; Wei-Dong Mi
Journal:  Membranes (Basel)       Date:  2022-03-11

9.  Developmental impact of glutamate transporter overexpression on dopaminergic neuron activity and stereotypic behavior.

Authors:  Jeremy Veenstra-VanderWeele; Susanne E Ahmari; Muhammad O Chohan; Jared M Kopelman; Hannah Yueh; Zeinab Fazlali; Natasha Greene; Alexander Z Harris; Peter D Balsam; E David Leonardo; Edgar R Kramer
Journal:  Mol Psychiatry       Date:  2022-01-20       Impact factor: 13.437

Review 10.  Dopamine dysfunction in stimulant use disorders: mechanistic comparisons and implications for treatment.

Authors:  Milky Kohno; Laura E Dennis; Holly McCready; William F Hoffman
Journal:  Mol Psychiatry       Date:  2021-06-11       Impact factor: 15.992
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.